Pharmacogenetic biomarkers of response in Crohn’s disease
نویسندگان
چکیده
منابع مشابه
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.
Antiangiogenic treatments have shown activity across multiple tumour types and in various settings. Despite having been approved on the basis of efficacy, the therapeutic index varies substantially in different settings for many of these agents. A major limitation is the current inability to personalise treatment a priori according to findings on measurement of a predictive biomarker. The roles...
متن کاملPinworm Infestation Mimicking Crohns' Disease
We here report a case of a young man who presented to his general practitioner with diarrhea. Inflammatory bowel disease was suspected and a colonoscopy showed aphthous lesions suggestive of Crohns' disease but biopsies revealed eggs of Enterobius vermicularis. When treated for this parasite, his symptoms were alleviated and a followup colonoscopy revealed a normal colon and distal ileum. Enter...
متن کاملChanges of Small Bowel Peristalsis in Patients with Crohns Disease
Purpose: MR enterography (MRE) is one of the mainstays in the evaluation of Crohns disease (CD). A wide variety of studies have attempted to improve the sensitivity and specificity of MRE, all focusing on the evaluation of static images [1]. MRE however allows not only the static display of morphology, but can be combined with ultrafast scanning techniques (cineMRE) for analysis of bowel motili...
متن کاملPharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives
Disease-modifying therapies (DMTs) have significantly advanced the treatment of relapsing multiple sclerosis (MS), decreasing the frequency of relapses, disability, and magnetic resonance imaging lesion formation. However, patients' responses to and tolerability of DMTs vary considerably, creating an unmet need for biomarkers to identify likely responders and/or those who may have treatment-lim...
متن کاملPharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients
Type 2 diabetes mellitus is a worldwide epidemic disorder with considerable health and economic consequences. Metformin is one of the most commonly prescribed oral antidiabetic drugs. Pharmacogenetic studies showed that variants in genes related to the pharmacokinetics of metformin were associated with glucose-lowering effect of metformin. The aim of this study was to evaluate pharmacogenetic v...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Pharmacogenomics Journal
سال: 2017
ISSN: 1470-269X,1473-1150
DOI: 10.1038/tpj.2017.27